NLNK Share Price

Open 10.79 Change Price %
High 11.42 1 Day 0.54 5.00
Low 10.79 1 Week -0.69 -5.74
Close 11.33 1 Month 1.14 11.19
Volume 239194 1 Year -15.83 -58.28
52 Week High 28.47
52 Week Low 9.23
NLNK Important Levels
Resistance 2 11.91
Resistance 1 11.67
Pivot 11.18
Support 1 10.99
Support 2 10.75
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

NewLink Genetics Corporation (NASDAQ: NLNK)

NLNK Technical Analysis 4
As on 20th Jan 2017 NLNK Share Price closed @ 11.33 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 13.24 & Sell for SHORT-TERM with Stoploss of 11.55 we also expect STOCK to react on Following IMPORTANT LEVELS.
NLNK Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
NLNK Other Details
Segment EQ
Market Capital 281938752.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.newlinkgenetics.com
NLNK Address
NLNK
2503 South Loop Drive
Ames, IA 50010
United States
Phone: 515-296-5555
Fax: 515-296-3520
NLNK Latest News
Interactive Technical Analysis Chart NewLink Genetics Corporation ( NLNK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NewLink Genetics Corporation
NLNK Business Profile
NewLink Genetics Corporation operates as a biopharmaceutical company. The Company, based in the United States, is focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians. Its HyperAcute cancer immunotherapies aim to treat non-small cell lung cancer, pancreatic cancer, melanoma, prostate cancer, and breast cancer.